The FDA implemented the breakthrough device program in 2015. The program was designed to expedite review of premarket approval (PMA), 510(k) clearance, and De Novo marketing.
Critics say there's a lot of red tape to the FDA approval process. However, when there are shortages for medications and other health products, that process looks a little different.
Critics say there's a lot of red tape to the FDA approval process. However, when there are shortages for medications and other health products, that process looks a little different.
Researchers found that mask mandates in Spain are not at all connected to a lower rate of Wuhan coronavirus (COVID-19) transmissions. For the study, they compared the incidence of COVID-19 in [.]